CLINICAL RESEARCH: EFFECTS OF STATIN THERAPY
Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy
Masamichi Takano, MD, PhD*,
Kyoichi Mizuno, MD, PhD, FACC*,*,
Shinya Yokoyama, MD*,
Koji Seimiya, MD*,
Fumiyuki Ishibashi, MD*,
Kentaro Okamatsu, MD* and
Ryota Uemura, MD, PhD*
* Department of Internal Medicine, Nippon Medical School, Chiba-Hokusoh Hospital, Imba, Chiba, Japan
Manuscript received October 16, 2002;
revised manuscript received February 10, 2003,
accepted February 20, 2003.
* Reprint requests and correspondence: Dr. Kyoichi Mizuno, Department of Internal Medicine, Nippon Medical School, Chiba-Hokusoh Hospital, 1715 Kamakari, Imba, Chiba, Japan 270-1694. mizunok{at}nms.ac.jp
OBJECTIVES: Changes in coronary plaque color and morphology by statin therapy were evaluated using coronary angioscopy.
BACKGROUND: Coronary plaque stabilization by statin therapy has not been clarified in humans.
METHODS: Thirty-one patients with coronary artery disease were divided into either the comparison group (n = 16) or the atorvastatin group (n = 15). Before treatment and 12 months after, the color and complexity of 145 coronary plaques were determined according to angioscopic findings. The yellow score of the plaque was defined as 0 (white), 1 (light yellow), 2 (yellow), or 3 (dark yellow), and its disrupted score was defined as 0 (smooth surface) or 1 (irregular surface) and as 0 (without thrombus) or 1 (with thrombus). In each patient, the mean yellow score and mean disrupted score were calculated.
RESULTS: Mean low-density lipoprotein cholesterol (LDL-C) decreased by 45% in the atorvastatin group, whereas an increase of 9% was seen in the comparison group. The mean yellow score decreased from 2.03 to 1.13 in the atorvastatin group, whereas it increased from 1.67 to 1.99 in the comparison group. There was a good correlation between the change in the mean yellow score and the change in LDL-C levels (r = 0.81, p < 0.0001). The change in the mean yellow score and mean disrupted score differed significantly between the two groups (p = 0.002 and p = 0.03, respectively).
CONCLUSIONS: This is the first report clarifying detailed changes in coronary plaque by statin in humans. This study indicated that lipid-lowering therapy changes plaque color and morphology and should then lead to coronary plaque stabilization.
|
Abbreviations and Acronyms
| | ACS | = acute coronary syndrome | | CRP | = C-reactive protein | | HDL-C | = high-density lipoprotein cholesterol | | IMT | = intima-media thickness | | LDL-C | = low-density lipoprotein cholesterol | | MI | = myocardial infarction | | PCI | = percutaneous coronary intervention | | T-CHO | = total cholesterol | | TG | = triglycerides |
|
This article has been cited by other articles:

|
 |

|
 |
 
A. Maehara, G. S. Mintz, and N. J. Weissman
Advances in Intravascular Imaging
Circ Cardiovasc Interv,
October 1, 2009;
2(5):
482 - 490.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nasu, E. Tsuchikane, O. Katoh, N. Tanaka, M. Kimura, M. Ehara, Y. Kinoshita, T. Matsubara, H. Matsuo, K. Asakura, et al.
Effect of Fluvastatin on Progression of Coronary Atherosclerotic Plaque Evaluated by Virtual Histology Intravascular Ultrasound
J. Am. Coll. Cardiol. Intv.,
July 1, 2009;
2(7):
689 - 696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yokoyama, M. Takano, M. Yamamoto, S. Inami, S. Sakai, K. Okamatsu, S. Okuni, K. Seimiya, D. Murakami, T. Ohba, et al.
Extended Follow-Up by Serial Angioscopic Observation for Bare-Metal Stents in Native Coronary Arteries: From Healing Response to Atherosclerotic Transformation of Neointima
Circ Cardiovasc Interv,
June 1, 2009;
2(3):
205 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Awata, S. Nanto, M. Uematsu, T. Morozumi, T. Watanabe, T. Onishi, O. Iida, F. Sera, H. Minamiguchi, J.-i. Kotani, et al.
Heterogeneous Arterial Healing in Patients Following Paclitaxel-Eluting Stent Implantation: Comparison With Sirolimus-Eluting Stents
J. Am. Coll. Cardiol. Intv.,
May 1, 2009;
2(5):
453 - 458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Awata, J.-i. Kotani, M. Uematsu, T. Morozumi, T. Watanabe, T. Onishi, O. Iida, F. Sera, S. Nanto, M. Hori, et al.
Serial Angioscopic Evidence of Incomplete Neointimal Coverage After Sirolimus-Eluting Stent Implantation: Comparison With Bare-Metal Stents
Circulation,
August 21, 2007;
116(8):
910 - 916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Waxman, F. Ishibashi, and J. E. Muller
Detection and Treatment of Vulnerable Plaques and Vulnerable Patients: Novel Approaches to Prevention of Coronary Events
Circulation,
November 28, 2006;
114(22):
2390 - 2411.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Takano, T. Ohba, S. Inami, K. Seimiya, S. Sakai, and K. Mizuno
Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation
Eur. Heart J.,
September 2, 2006;
27(18):
2189 - 2195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ohtani, Y. Ueda, I. Mizote, J. Oyabu, K. Okada, A. Hirayama, and K. Kodama
Number of Yellow Plaques Detected in a Coronary Artery Is Associated With Future Risk of Acute Coronary Syndrome: Detection of Vulnerable Patients by Angioscopy
J. Am. Coll. Cardiol.,
June 6, 2006;
47(11):
2194 - 2200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. Narula, E. Mahmud, and S. Tsimikas
Imaging vulnerable plaque by ultrasound.
J. Am. Coll. Cardiol.,
April 18, 2006;
47(8 Suppl):
C32 - C39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Iwakura, H. Ito, S. Kawano, A. Okamura, T. Kurotobi, M. Date, K. Inoue, and K. Fujii
Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction
Eur. Heart J.,
March 1, 2006;
27(5):
534 - 539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Watanabe, S. Sugiyama, K. Kugiyama, O. Honda, H. Fukushima, H. Koga, Y. Horibata, T. Hirai, T. Sakamoto, M. Yoshimura, et al.
Stabilization of Carotid Atheroma Assessed by Quantitative Ultrasound Analysis in Nonhypercholesterolemic Patients With Coronary Artery Disease
J. Am. Coll. Cardiol.,
December 6, 2005;
46(11):
2022 - 2030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kawasaki, K. Sano, M. Okubo, H. Yokoyama, Y. Ito, I. Murata, K. Tsuchiya, S. Minatoguchi, X. Zhou, H. Fujita, et al.
Volumetric Quantitative Analysis of Tissue Characteristics of Coronary Plaques After Statin Therapy Using Three-Dimensional Integrated Backscatter Intravascular Ultrasound
J. Am. Coll. Cardiol.,
June 21, 2005;
45(12):
1946 - 1953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Takano, S. Inami, F. Ishibashi, K. Okamatsu, K. Seimiya, T. Ohba, S. Sakai, and K. Mizuno
Angioscopic follow-up study of coronary ruptured plaques in nonculprit lesions
J. Am. Coll. Cardiol.,
March 1, 2005;
45(5):
652 - 658.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|